China Health Group Inc. (HKG:8225)

Market Cap	163.24M
Revenue (ttm)	28.15M
Net Income (ttm)	-15.45M
Shares Out	995.35M
EPS (ttm)	-0.02
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	60,000
Average Volume	193,500
Open	0.1630
Previous Close	0.1640
Day's Range	0.1630 - 0.1650
52-Week Range	0.0710 - 0.2440
Beta	0.19
RSI	43.55
Earnings Date	Aug 13, 2025

About China Health Group

China Health Group Inc., an investment holding company, researches and develops drugs, bio drugs, natural drugs, and synthetic drugs in the People’s Republic of China. The company offers contracted pharmaceutical development and clinical research, and post market; and post launch market research, medical science, and medical market services. It also provides hospital management, clinical research and promotion, rehabilitation tourism, and specialty hospital services, as well as Wanquan cloud health services. In addition, the company offers phar...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1998
• Employees: 42
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 8225

Financial Performance

In 2024, China Health Group's revenue was 26.45 million, an increase of 23.47% compared to the previous year's 21.43 million. Losses were -14.52 million, -74.97% less than in 2023.

Financial numbers in CNY